The Helen Hayes Hospital Clinical Research Center in West Haverstraw is is conducting a clinical research study to test an investigational medication for Osteoporosis
Qualified participants will receive all study-related care, including physician visits, laboratory services and study medications.
To be eligible for the study, a woman must be postmenopausal, between 55 and 85 years of age. In addition, the individual must have been diagnosed with osteopenia/osteoporosis and have been taking alendronate (Fosamax®) for at least one year.
Osteoporosis is a serious health concern worldwide. It is a preventable disease which causes weakening of the bones and a loss of bone mass, resulting in fractures and disability. The disease is expected to affect one in every two women. Helen Hayes Hospital is one of the country’s leading centers in osteoporosis research.
For more information on this study, contact Nancy Barbuto, R.N., at 845-786-4804 or email@example.com.